Browse 18 Health Care companies funded by Matrix Partners China. See funding amounts, founder contacts, and investment details.
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.
Alioth focuses on the development and application of technical products for pharmaceutical process technology.
Jiajin Biotech is a pharmaceutical R&D service provider.
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.
Haoyayi is an online dental medical service platform.
Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery.
TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer.
LinkedCare is a consumer medical digital service platform that provides operation and management solutions for consumer medical enterprises.
Weimai uses big data and artificial intelligence to digitize their healthcare service platform.
Headlight is a mental health firm that aims to change the way mental health services are delivered.
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on small molecule drugs for cancer and autoimmune diseases.
Onechip Bioelectronics develops biosensor chips and nanomaterials.
Qihan Biotech is a gene-editing organ transplantation technology developer.
UNIMED provides integrated medical service models.
Nutshell Therapeutics invents small molecules in the realm of drug discovery fostered by protein dynamics.
View all companies funded by Matrix Partners China across every industry and funding stage.
View Full Matrix Partners China Portfolio